COST-EFFECTIVENESS OF PHARMACOTHERAPIES FOR NICOTINE DEPENDENCE IN PRIMARY CARE SETTINGS: A MULTINATIONAL COMPARISON
Zapisane w:
CORNUZ, J., ET AL., COST-EFFECTIVENESS OF PHARMACOTHERAPIES FOR NICOTINE DEPENDENCE IN PRIMARY CARE SETTINGS: A MULTINATIONAL COMPARISON. TOBACCO CONTROL, Vol. 15, no. 3 (2006), p. 152-159.
Ref.
140124
Lokalizacja:
SIIS R.1048
Palabras clave:
Análisis coste-eficacia, Atención primaria, Drogodependencias, Efectos, Evaluación de servicios, Programas de desintoxicación, Programas de mantenimiento, Tabaquismo, Tratamiento médico, Panorama internacional
Análisis coste-eficacia, Atención primaria, Drogodependencias, Efectos, Evaluación de servicios, Programas de desintoxicación, Programas de mantenimiento, Tabaquismo, Tratamiento médico, Panorama internacional
Podobne zapisy: COST-EFFECTIVENESS OF PHARMACOTHERAPIES FOR NICOTINE DEPENDENCE IN PRIMARY CARE SETTINGS: A MULTINATIONAL COMPARISON
- COSTS AND BENEFITS OF SMOKING CESSATION AIDS: MAKING A CASE FOR PUBLIC REIMBURSEMENT OF NICOTINE REPLACEMENT THERAPY IN AUSTRALIA
- COST EFFECTIVENESS OF DISULFIRAM: TREATING COCAINE USE IN METHADONE-MAINTAINED PATIENTS
- A COST-EFFECTIVENESS ANALYSIS OF HEROIN DETOXIFICATION METHODS IN THE AUSTRALIAN NATIONAL EVALUATION OF PHARMACOTHERAPIES FOR OPIOID DEPENDENCE (NEPOD)
- A RAW DEAL? IMPACT ON THE HEALTH OF CONSUMERS RELATIVE TO THE COST OF PHARMACOTHERAPY
- COST ANALYSIS OF CLINIC AND OFFICE-BASED TREATMENT OF OPIOID DEPENDENCE: RESULTS WITH METHADONE AND BUPRENORPHINE IN CLINICALLY STABLE PATIENTS
- DAY TREATMENT VERSUS ENHANCED STANDARD METHADONE SERVICES FOR OPIOID-DEPENDENT PATIENTS: A COMPARISON OF CLINICAL EFFICACY AND COST